JP2012533541A5 - - Google Patents

Info

Publication number

JP2012533541A5

JP2012533541A5 JP2012520630A JP2012520630A JP2012533541A5 JP 2012533541 A5 JP2012533541 A5 JP 2012533541A5 JP 2012520630 A JP2012520630 A JP 2012520630A JP 2012520630 A JP2012520630 A JP 2012520630A JP 2012533541 A5 JP2012533541 A5 JP 2012533541A5

Authority

JP

Japan

Prior art keywords

compound

pharmaceutically acceptable

cancer

acceptable salt

unsubstituted

Prior art date

2010-07-15

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 150000001875 compounds Chemical class 0.000 claims description 98
• 150000003839 salts Chemical class 0.000 claims description 79
• 229910052739 hydrogen Inorganic materials 0.000 claims description 34
• 239000001257 hydrogen Substances 0.000 claims description 34
• 206010028980 Neoplasm Diseases 0.000 claims description 33
• 150000002431 hydrogen Chemical class 0.000 claims description 30
• 201000011510 cancer Diseases 0.000 claims description 25
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 18
• 206010025323 Lymphomas Diseases 0.000 claims description 14
• 208000031261 Acute myeloid leukaemia Diseases 0.000 claims description 8
• 201000003793 Myelodysplastic syndrome Diseases 0.000 claims description 8
• 208000009956 adenocarcinoma Diseases 0.000 claims description 8
• 210000004027 cell Anatomy 0.000 claims description 8
• 208000032839 leukemia Diseases 0.000 claims description 8
• 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 claims description 7
• 206010061218 Inflammation Diseases 0.000 claims description 7
• 208000033776 Myeloid Acute Leukemia Diseases 0.000 claims description 7
• 201000010099 disease Diseases 0.000 claims description 7
• 230000004054 inflammatory process Effects 0.000 claims description 7
• 206010041823 squamous cell carcinoma Diseases 0.000 claims description 7
• 208000010833 Chronic myeloid leukaemia Diseases 0.000 claims description 6
• 201000004624 Dermatitis Diseases 0.000 claims description 6
• 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 claims description 6
• 208000006673 asthma Diseases 0.000 claims description 6
• 208000004232 Enteritis Diseases 0.000 claims description 5
• 208000007465 Giant cell arteritis Diseases 0.000 claims description 5
• 206010035226 Plasma cell myeloma Diseases 0.000 claims description 5
• 230000003211 malignant effect Effects 0.000 claims description 5
• 208000024893 Acute lymphoblastic leukemia Diseases 0.000 claims description 4
• 208000014697 Acute lymphocytic leukaemia Diseases 0.000 claims description 4
• 206010003571 Astrocytoma Diseases 0.000 claims description 4
• 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 claims description 4
• 206010008342 Cervix carcinoma Diseases 0.000 claims description 4
• 208000011231 Crohn disease Diseases 0.000 claims description 4
• 206010012442 Dermatitis contact Diseases 0.000 claims description 4
• 208000017604 Hodgkin disease Diseases 0.000 claims description 4
• 208000010747 Hodgkins lymphoma Diseases 0.000 claims description 4
• 208000008839 Kidney Neoplasms Diseases 0.000 claims description 4
• 208000031671 Large B-Cell Diffuse Lymphoma Diseases 0.000 claims description 4
• 208000034578 Multiple myelomas Diseases 0.000 claims description 4
• 208000014767 Myeloproliferative disease Diseases 0.000 claims description 4
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims description 4
• 206010031096 Oropharyngeal cancer Diseases 0.000 claims description 4
• 206010057444 Oropharyngeal neoplasm Diseases 0.000 claims description 4
• 206010061535 Ovarian neoplasm Diseases 0.000 claims description 4
• 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims description 4
• 206010060862 Prostate cancer Diseases 0.000 claims description 4
• 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 4
• 201000004681 Psoriasis Diseases 0.000 claims description 4
• 206010037596 Pyelonephritis Diseases 0.000 claims description 4
• 206010038389 Renal cancer Diseases 0.000 claims description 4
• 208000005718 Stomach Neoplasms Diseases 0.000 claims description 4
• 208000024770 Thyroid neoplasm Diseases 0.000 claims description 4
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims description 4
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims description 4
• 241000700605 Viruses Species 0.000 claims description 4
• 206010003230 arteritis Diseases 0.000 claims description 4
• 210000003719 b-lymphocyte Anatomy 0.000 claims description 4
• 208000002458 carcinoid tumor Diseases 0.000 claims description 4
• 201000007455 central nervous system cancer Diseases 0.000 claims description 4
• 201000010881 cervical cancer Diseases 0.000 claims description 4
• 206010009887 colitis Diseases 0.000 claims description 4
• 208000010247 contact dermatitis Diseases 0.000 claims description 4
• 206010012818 diffuse large B-cell lymphoma Diseases 0.000 claims description 4
• 206010017758 gastric cancer Diseases 0.000 claims description 4
• 208000006454 hepatitis Diseases 0.000 claims description 4
• 231100000283 hepatitis Toxicity 0.000 claims description 4
• 201000010982 kidney cancer Diseases 0.000 claims description 4
• 208000008585 mastocytosis Diseases 0.000 claims description 4
• 201000001441 melanoma Diseases 0.000 claims description 4
• 206010027191 meningioma Diseases 0.000 claims description 4
• 208000007538 neurilemmoma Diseases 0.000 claims description 4
• 201000006958 oropharynx cancer Diseases 0.000 claims description 4
• 208000008494 pericarditis Diseases 0.000 claims description 4
• 210000001428 peripheral nervous system Anatomy 0.000 claims description 4
• 206010034674 peritonitis Diseases 0.000 claims description 4
• 206010039073 rheumatoid arthritis Diseases 0.000 claims description 4
• 201000011549 stomach cancer Diseases 0.000 claims description 4
• 230000009885 systemic effect Effects 0.000 claims description 4
• 208000008732 thymoma Diseases 0.000 claims description 4
• 201000002510 thyroid cancer Diseases 0.000 claims description 4
• 206010005003 Bladder cancer Diseases 0.000 claims description 3
• 208000003174 Brain Neoplasms Diseases 0.000 claims description 3
• 206010009900 Colitis ulcerative Diseases 0.000 claims description 3
• 206010009944 Colon cancer Diseases 0.000 claims description 3
• 206010010741 Conjunctivitis Diseases 0.000 claims description 3
• 208000032612 Glial tumor Diseases 0.000 claims description 3
• 206010018338 Glioma Diseases 0.000 claims description 3
• 206010072579 Granulomatosis with polyangiitis Diseases 0.000 claims description 3
• 241000711549 Hepacivirus C Species 0.000 claims description 3
• 241000701806 Human papillomavirus Species 0.000 claims description 3
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
• 208000007766 Kaposi sarcoma Diseases 0.000 claims description 3
• 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 claims description 3
• 208000006644 Malignant Fibrous Histiocytoma Diseases 0.000 claims description 3
• 208000034176 Neoplasms, Germ Cell and Embryonal Diseases 0.000 claims description 3
• 206010033128 Ovarian cancer Diseases 0.000 claims description 3
• 206010061902 Pancreatic neoplasm Diseases 0.000 claims description 3
• 201000007100 Pharyngitis Diseases 0.000 claims description 3
• 206010036774 Proctitis Diseases 0.000 claims description 3
• 208000033464 Reiter syndrome Diseases 0.000 claims description 3
• 201000000582 Retinoblastoma Diseases 0.000 claims description 3
• 208000001106 Takayasu Arteritis Diseases 0.000 claims description 3
• 208000024313 Testicular Neoplasms Diseases 0.000 claims description 3
• 206010057644 Testis cancer Diseases 0.000 claims description 3
• 208000000728 Thymus Neoplasms Diseases 0.000 claims description 3
• 201000006704 Ulcerative Colitis Diseases 0.000 claims description 3
• 208000015778 Undifferentiated pleomorphic sarcoma Diseases 0.000 claims description 3
• 206010046851 Uveitis Diseases 0.000 claims description 3
• 208000010668 atopic eczema Diseases 0.000 claims description 3
• 206010006451 bronchitis Diseases 0.000 claims description 3
• 208000032852 chronic lymphocytic leukemia Diseases 0.000 claims description 3
• 201000007270 liver cancer Diseases 0.000 claims description 3
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 3
• 208000025113 myeloid leukemia Diseases 0.000 claims description 3
• 208000002154 non-small cell lung carcinoma Diseases 0.000 claims description 3
• 201000002528 pancreatic cancer Diseases 0.000 claims description 3
• 208000008443 pancreatic carcinoma Diseases 0.000 claims description 3
• 208000001297 phlebitis Diseases 0.000 claims description 3
• 208000002574 reactive arthritis Diseases 0.000 claims description 3
• 206010039083 rhinitis Diseases 0.000 claims description 3
• 201000000306 sarcoidosis Diseases 0.000 claims description 3
• 206010043207 temporal arteritis Diseases 0.000 claims description 3
• 201000003120 testicular cancer Diseases 0.000 claims description 3
• 206010044412 transitional cell carcinoma Diseases 0.000 claims description 3
• 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims description 3
• 201000005112 urinary bladder cancer Diseases 0.000 claims description 3
• 208000016683 Adult T-cell leukemia/lymphoma Diseases 0.000 claims description 2
• 201000001320 Atherosclerosis Diseases 0.000 claims description 2
• 206010003827 Autoimmune hepatitis Diseases 0.000 claims description 2
• 206010004146 Basal cell carcinoma Diseases 0.000 claims description 2
• 206010005949 Bone cancer Diseases 0.000 claims description 2
• 208000018084 Bone neoplasm Diseases 0.000 claims description 2
• 206010006187 Breast cancer Diseases 0.000 claims description 2
• 208000026310 Breast neoplasm Diseases 0.000 claims description 2
• 206010006811 Bursitis Diseases 0.000 claims description 2
• 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims description 2
• 206010014967 Ependymoma Diseases 0.000 claims description 2
• 208000007882 Gastritis Diseases 0.000 claims description 2
• 208000005577 Gastroenteritis Diseases 0.000 claims description 2
• 201000010915 Glioblastoma multiforme Diseases 0.000 claims description 2
• 206010018364 Glomerulonephritis Diseases 0.000 claims description 2
• 241000700721 Hepatitis B virus Species 0.000 claims description 2
• 206010020751 Hypersensitivity Diseases 0.000 claims description 2
• 206010021042 Hypopharyngeal cancer Diseases 0.000 claims description 2
• 206010056305 Hypopharyngeal neoplasm Diseases 0.000 claims description 2
• 208000005726 Inflammatory Breast Neoplasms Diseases 0.000 claims description 2
• 208000022559 Inflammatory bowel disease Diseases 0.000 claims description 2
• 206010023825 Laryngeal cancer Diseases 0.000 claims description 2
• 201000004462 Leydig Cell Tumor Diseases 0.000 claims description 2
• 208000000172 Medulloblastoma Diseases 0.000 claims description 2
• 206010027193 Meningioma malignant Diseases 0.000 claims description 2
• 208000001894 Nasopharyngeal Neoplasms Diseases 0.000 claims description 2
• 206010061306 Nasopharyngeal cancer Diseases 0.000 claims description 2
• 201000004404 Neurofibroma Diseases 0.000 claims description 2
• 201000010133 Oligodendroglioma Diseases 0.000 claims description 2
• 208000015634 Rectal Neoplasms Diseases 0.000 claims description 2
• 201000010208 Seminoma Diseases 0.000 claims description 2
• 208000003274 Sertoli cell tumor Diseases 0.000 claims description 2
• 206010041067 Small cell lung cancer Diseases 0.000 claims description 2
• 206010047115 Vasculitis Diseases 0.000 claims description 2
• 208000004064 acoustic neuroma Diseases 0.000 claims description 2
• 201000006966 adult T-cell leukemia Diseases 0.000 claims description 2
• 206010002224 anaplastic astrocytoma Diseases 0.000 claims description 2
• 201000008937 atopic dermatitis Diseases 0.000 claims description 2
• 201000001352 cholecystitis Diseases 0.000 claims description 2
• 208000029742 colonic neoplasm Diseases 0.000 claims description 2
• 201000003146 cystitis Diseases 0.000 claims description 2
• 206010014665 endocarditis Diseases 0.000 claims description 2
• 208000007565 gingivitis Diseases 0.000 claims description 2
• 208000005017 glioblastoma Diseases 0.000 claims description 2
• 230000002710 gonadal effect Effects 0.000 claims description 2
• 208000030316 grade III meningioma Diseases 0.000 claims description 2
• 201000006866 hypopharynx cancer Diseases 0.000 claims description 2
• 208000009326 ileitis Diseases 0.000 claims description 2
• 230000002757 inflammatory effect Effects 0.000 claims description 2
• 206010023841 laryngeal neoplasm Diseases 0.000 claims description 2
• 208000006178 malignant mesothelioma Diseases 0.000 claims description 2
• 201000009020 malignant peripheral nerve sheath tumor Diseases 0.000 claims description 2
• 208000004396 mastitis Diseases 0.000 claims description 2
• 201000010225 mixed cell type cancer Diseases 0.000 claims description 2
• 208000029638 mixed neoplasm Diseases 0.000 claims description 2
• 201000008383 nephritis Diseases 0.000 claims description 2
• 208000029974 neurofibrosarcoma Diseases 0.000 claims description 2
• 201000008482 osteoarthritis Diseases 0.000 claims description 2
• 230000002093 peripheral effect Effects 0.000 claims description 2
• 208000008423 pleurisy Diseases 0.000 claims description 2
• 201000007094 prostatitis Diseases 0.000 claims description 2
• 206010038038 rectal cancer Diseases 0.000 claims description 2
• 201000001275 rectum cancer Diseases 0.000 claims description 2
• 208000037803 restenosis Diseases 0.000 claims description 2
• 208000000649 small cell carcinoma Diseases 0.000 claims description 2
• 208000000587 small cell lung carcinoma Diseases 0.000 claims description 2
• 238000011282 treatment Methods 0.000 claims description 2
• 239000008194 pharmaceutical composition Substances 0.000 claims 43
• 125000005843 halogen group Chemical group 0.000 claims 26
• -1 cyano, hydroxy Chemical group 0.000 claims 25
• 125000000217 alkyl group Chemical group 0.000 claims 21
• 125000000592 heterocycloalkyl group Chemical group 0.000 claims 17
• 125000001072 heteroaryl group Chemical group 0.000 claims 13
• 125000000753 cycloalkyl group Chemical group 0.000 claims 11
• 208000035475 disorder Diseases 0.000 claims 11
• 125000003118 aryl group Chemical group 0.000 claims 10
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 10
• 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 10
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 10
• 125000003342 alkenyl group Chemical group 0.000 claims 9
• 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 9
• 125000000304 alkynyl group Chemical group 0.000 claims 9
• 125000003545 alkoxy group Chemical group 0.000 claims 8
• 150000001408 amides Chemical class 0.000 claims 8
• 125000004093 cyano group Chemical group *C#N 0.000 claims 8
• 125000005420 sulfonamido group Chemical group S(=O)(=O)(N*)* 0.000 claims 8
• 108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 claims 6
• 102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 claims 6
• 239000003814 drug Substances 0.000 claims 6
• 208000026278 immune system disease Diseases 0.000 claims 6
• 125000002252 acyl group Chemical group 0.000 claims 5
• 208000027866 inflammatory disease Diseases 0.000 claims 5
• 125000005017 substituted alkenyl group Chemical group 0.000 claims 5
• 125000000547 substituted alkyl group Chemical group 0.000 claims 5
• 125000004426 substituted alkynyl group Chemical group 0.000 claims 5
• 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 5
• 208000003343 Antiphospholipid Syndrome Diseases 0.000 claims 4
• AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims 4
• 208000035895 Guillain-Barré syndrome Diseases 0.000 claims 4
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 claims 4
• 206010049567 Miller Fisher syndrome Diseases 0.000 claims 4
• 208000005225 Opsoclonus-Myoclonus Syndrome Diseases 0.000 claims 4
• 208000002552 acute disseminated encephalomyelitis Diseases 0.000 claims 4
• 239000002246 antineoplastic agent Substances 0.000 claims 4
• 229940127089 cytotoxic agent Drugs 0.000 claims 4
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 4
• 239000003112 inhibitor Substances 0.000 claims 4
• 206010025135 lupus erythematosus Diseases 0.000 claims 4
• 229960000485 methotrexate Drugs 0.000 claims 4
• 229940124597 therapeutic agent Drugs 0.000 claims 4
• WYWHKKSPHMUBEB-UHFFFAOYSA-N tioguanine Chemical compound N1C(N)=NC(=S)C2=C1N=CN2 WYWHKKSPHMUBEB-UHFFFAOYSA-N 0.000 claims 4
• NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 claims 3
• 208000012902 Nervous system disease Diseases 0.000 claims 3
• 108091007960 PI3Ks Proteins 0.000 claims 3
• 206010039710 Scleroderma Diseases 0.000 claims 3
• 206010003246 arthritis Diseases 0.000 claims 3
• 206010012601 diabetes mellitus Diseases 0.000 claims 3
• 208000019622 heart disease Diseases 0.000 claims 3
• 125000004446 heteroarylalkyl group Chemical group 0.000 claims 3
• GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 claims 3
• 206010039667 schwannoma Diseases 0.000 claims 3
• 125000003107 substituted aryl group Chemical group 0.000 claims 3
• LKJPYSCBVHEWIU-KRWDZBQOSA-N (R)-bicalutamide Chemical compound C([C@@](O)(C)C(=O)NC=1C=C(C(C#N)=CC=1)C(F)(F)F)S(=O)(=O)C1=CC=C(F)C=C1 LKJPYSCBVHEWIU-KRWDZBQOSA-N 0.000 claims 2
• IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 claims 2
• STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 claims 2
• 208000026872 Addison Disease Diseases 0.000 claims 2
• 201000004384 Alopecia Diseases 0.000 claims 2
• 206010001935 American trypanosomiasis Diseases 0.000 claims 2
• 108010058207 Anistreplase Proteins 0.000 claims 2
• 208000032467 Aplastic anaemia Diseases 0.000 claims 2
• 208000023275 Autoimmune disease Diseases 0.000 claims 2
• 206010061666 Autonomic neuropathy Diseases 0.000 claims 2
• 208000023328 Basedow disease Diseases 0.000 claims 2
• 208000008439 Biliary Liver Cirrhosis Diseases 0.000 claims 2
• 208000033222 Biliary cirrhosis primary Diseases 0.000 claims 2
• GAGWJHPBXLXJQN-UORFTKCHSA-N Capecitabine Chemical compound C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](C)O1 GAGWJHPBXLXJQN-UORFTKCHSA-N 0.000 claims 2
• KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 claims 2
• BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 2
• 208000024699 Chagas disease Diseases 0.000 claims 2
• 206010008874 Chronic Fatigue Syndrome Diseases 0.000 claims 2
• 208000015943 Coeliac disease Diseases 0.000 claims 2
• 108010092160 Dactinomycin Proteins 0.000 claims 2
• 206010014561 Emphysema Diseases 0.000 claims 2
• 201000009273 Endometriosis Diseases 0.000 claims 2
• GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims 2
• 208000021309 Germ cell tumor Diseases 0.000 claims 2
• 208000024869 Goodpasture syndrome Diseases 0.000 claims 2
• 208000015023 Graves' disease Diseases 0.000 claims 2
• 208000001204 Hashimoto Disease Diseases 0.000 claims 2
• 208000030836 Hashimoto thyroiditis Diseases 0.000 claims 2
• 208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 claims 2
• 206010053574 Immunoblastic lymphoma Diseases 0.000 claims 2
• 108010005716 Interferon beta-1a Proteins 0.000 claims 2
• 208000005615 Interstitial Cystitis Diseases 0.000 claims 2
• 206010061252 Intraocular melanoma Diseases 0.000 claims 2
• 208000025205 Mantle-Cell Lymphoma Diseases 0.000 claims 2
• 208000003445 Mouth Neoplasms Diseases 0.000 claims 2
• 201000007224 Myeloproliferative neoplasm Diseases 0.000 claims 2
• ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 claims 2
• 208000003435 Optic Neuritis Diseases 0.000 claims 2
• 229910019142 PO4 Inorganic materials 0.000 claims 2
• 241000721454 Pemphigus Species 0.000 claims 2
• 206010036030 Polyarthritis Diseases 0.000 claims 2
• 208000012654 Primary biliary cholangitis Diseases 0.000 claims 2
• 208000000453 Skin Neoplasms Diseases 0.000 claims 2
• 206010042971 T-cell lymphoma Diseases 0.000 claims 2
• 208000027585 T-cell non-Hodgkin lymphoma Diseases 0.000 claims 2
• NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 claims 2
• FOCVUCIESVLUNU-UHFFFAOYSA-N Thiotepa Chemical group C1CN1P(N1CC1)(=S)N1CC1 FOCVUCIESVLUNU-UHFFFAOYSA-N 0.000 claims 2
• 208000007536 Thrombosis Diseases 0.000 claims 2
• 108090000373 Tissue Plasminogen Activator Proteins 0.000 claims 2
• 102000003978 Tissue Plasminogen Activator Human genes 0.000 claims 2
• 241000223109 Trypanosoma cruzi Species 0.000 claims 2
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 2
• 201000005969 Uveal melanoma Diseases 0.000 claims 2
• 206010047642 Vitiligo Diseases 0.000 claims 2
• RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 claims 2
• 125000004423 acyloxy group Chemical group 0.000 claims 2
• 231100000360 alopecia Toxicity 0.000 claims 2
• 201000000448 autoimmune hemolytic anemia Diseases 0.000 claims 2
• 229960000997 bicalutamide Drugs 0.000 claims 2
• GXJABQQUPOEUTA-RDJZCZTQSA-N bortezomib Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)B(O)O)NC(=O)C=1N=CC=NC=1)C1=CC=CC=C1 GXJABQQUPOEUTA-RDJZCZTQSA-N 0.000 claims 2
• 239000004202 carbamide Substances 0.000 claims 2
• ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 claims 2
• JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 claims 2
• 229960004630 chlorambucil Drugs 0.000 claims 2
• 208000025302 chronic primary adrenal insufficiency Diseases 0.000 claims 2
• 230000001886 ciliary effect Effects 0.000 claims 2
• 238000011260 co-administration Methods 0.000 claims 2
• 239000003246 corticosteroid Substances 0.000 claims 2
• STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 claims 2
• CTSPAMFJBXKSOY-UHFFFAOYSA-N ellipticine Chemical compound N1=CC=C2C(C)=C(NC=3C4=CC=CC=3)C4=C(C)C2=C1 CTSPAMFJBXKSOY-UHFFFAOYSA-N 0.000 claims 2
• 229960002949 fluorouracil Drugs 0.000 claims 2
• CHPZKNULDCNCBW-UHFFFAOYSA-N gallium nitrate Chemical compound [Ga+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O CHPZKNULDCNCBW-UHFFFAOYSA-N 0.000 claims 2
• 208000014829 head and neck neoplasm Diseases 0.000 claims 2
• 125000004404 heteroalkyl group Chemical group 0.000 claims 2
• 210000003630 histaminocyte Anatomy 0.000 claims 2
• 229960001101 ifosfamide Drugs 0.000 claims 2
• HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 claims 2
• CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 claims 2
• 230000005764 inhibitory process Effects 0.000 claims 2
• GURKHSYORGJETM-WAQYZQTGSA-N irinotecan hydrochloride (anhydrous) Chemical compound Cl.C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 GURKHSYORGJETM-WAQYZQTGSA-N 0.000 claims 2
• 208000012987 lip and oral cavity carcinoma Diseases 0.000 claims 2
• 229960001428 mercaptopurine Drugs 0.000 claims 2
• 229960004857 mitomycin Drugs 0.000 claims 2
• 229960001156 mitoxantrone Drugs 0.000 claims 2
• KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 claims 2
• 201000006417 multiple sclerosis Diseases 0.000 claims 2
• 210000003205 muscle Anatomy 0.000 claims 2
• 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 claims 2
• 230000002232 neuromuscular Effects 0.000 claims 2
• 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims 2
• 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims 2
• 201000002575 ocular melanoma Diseases 0.000 claims 2
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 2
• 239000010452 phosphate Substances 0.000 claims 2
• BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims 2
• 208000030428 polyarticular arthritis Diseases 0.000 claims 2
• 108090000765 processed proteins & peptides Proteins 0.000 claims 2
• RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 claims 2
• 208000023504 respiratory system disease Diseases 0.000 claims 2
• YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims 2
• 201000000849 skin cancer Diseases 0.000 claims 2
• 150000003384 small molecules Chemical class 0.000 claims 2
• PVYJZLYGTZKPJE-UHFFFAOYSA-N streptonigrin Chemical compound C=1C=C2C(=O)C(OC)=C(N)C(=O)C2=NC=1C(C=1N)=NC(C(O)=O)=C(C)C=1C1=CC=C(OC)C(OC)=C1O PVYJZLYGTZKPJE-UHFFFAOYSA-N 0.000 claims 2
• 208000024891 symptom Diseases 0.000 claims 2
• 206010043778 thyroiditis Diseases 0.000 claims 2
• 229960003087 tioguanine Drugs 0.000 claims 2
• 229960000187 tissue plasminogen activator Drugs 0.000 claims 2
• QFJCIRLUMZQUOT-KADBNGAOSA-N (1R,9S,12S,15R,16E,18R,19R,21R,23S,24Z,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)\C(C)=C\C=C\C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-KADBNGAOSA-N 0.000 claims 1
• WDQLRUYAYXDIFW-RWKIJVEZSA-N (2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-4-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 WDQLRUYAYXDIFW-RWKIJVEZSA-N 0.000 claims 1
• FLWWDYNPWOSLEO-HQVZTVAUSA-N (2s)-2-[[4-[1-(2-amino-4-oxo-1h-pteridin-6-yl)ethyl-methylamino]benzoyl]amino]pentanedioic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1C(C)N(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FLWWDYNPWOSLEO-HQVZTVAUSA-N 0.000 claims 1
• CGMTUJFWROPELF-YPAAEMCBSA-N (3E,5S)-5-[(2S)-butan-2-yl]-3-(1-hydroxyethylidene)pyrrolidine-2,4-dione Chemical compound CC[C@H](C)[C@@H]1NC(=O)\C(=C(/C)O)C1=O CGMTUJFWROPELF-YPAAEMCBSA-N 0.000 claims 1
• FPVKHBSQESCIEP-UHFFFAOYSA-N (8S)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol Natural products C1C(O)C(CO)OC1N1C(NC=NCC2O)=C2N=C1 FPVKHBSQESCIEP-UHFFFAOYSA-N 0.000 claims 1
• IEXUMDBQLIVNHZ-YOUGDJEHSA-N (8s,11r,13r,14s,17s)-11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(3-hydroxypropyl)-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(O)CCCO)[C@@]2(C)C1 IEXUMDBQLIVNHZ-YOUGDJEHSA-N 0.000 claims 1
• FDKXTQMXEQVLRF-ZHACJKMWSA-N (E)-dacarbazine Chemical compound CN(C)\N=N\c1[nH]cnc1C(N)=O FDKXTQMXEQVLRF-ZHACJKMWSA-N 0.000 claims 1
• WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 claims 1
• AGNGYMCLFWQVGX-AGFFZDDWSA-N (e)-1-[(2s)-2-amino-2-carboxyethoxy]-2-diazonioethenolate Chemical compound OC(=O)[C@@H](N)CO\C([O-])=C\[N+]#N AGNGYMCLFWQVGX-AGFFZDDWSA-N 0.000 claims 1
• VSNHCAURESNICA-NJFSPNSNSA-N 1-oxidanylurea Chemical compound N[14C](=O)NO VSNHCAURESNICA-NJFSPNSNSA-N 0.000 claims 1
• BTOTXLJHDSNXMW-POYBYMJQSA-N 2,3-dideoxyuridine Chemical compound O1[C@H](CO)CC[C@@H]1N1C(=O)NC(=O)C=C1 BTOTXLJHDSNXMW-POYBYMJQSA-N 0.000 claims 1
• QCXJFISCRQIYID-IAEPZHFASA-N 2-amino-1-n-[(3s,6s,7r,10s,16s)-3-[(2s)-butan-2-yl]-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-10-propan-2-yl-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-4,6-dimethyl-3-oxo-9-n-[(3s,6s,7r,10s,16s)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propa Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N=C2C(C(=O)N[C@@H]3C(=O)N[C@H](C(N4CCC[C@H]4C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]3C)=O)[C@@H](C)CC)=C(N)C(=O)C(C)=C2O2)C2=C(C)C=C1 QCXJFISCRQIYID-IAEPZHFASA-N 0.000 claims 1
• NDMPLJNOPCLANR-UHFFFAOYSA-N 3,4-dihydroxy-15-(4-hydroxy-18-methoxycarbonyl-5,18-seco-ibogamin-18-yl)-16-methoxy-1-methyl-6,7-didehydro-aspidospermidine-3-carboxylic acid methyl ester Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 NDMPLJNOPCLANR-UHFFFAOYSA-N 0.000 claims 1
• PWMYMKOUNYTVQN-UHFFFAOYSA-N 3-(8,8-diethyl-2-aza-8-germaspiro[4.5]decan-2-yl)-n,n-dimethylpropan-1-amine Chemical compound C1C[Ge](CC)(CC)CCC11CN(CCCN(C)C)CC1 PWMYMKOUNYTVQN-UHFFFAOYSA-N 0.000 claims 1
• AOJJSUZBOXZQNB-VTZDEGQISA-N 4'-epidoxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-VTZDEGQISA-N 0.000 claims 1
• DODQJNMQWMSYGS-QPLCGJKRSA-N 4-[(z)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-phenylbut-1-en-2-yl]phenol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 DODQJNMQWMSYGS-QPLCGJKRSA-N 0.000 claims 1
• TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 claims 1
• IDPUKCWIGUEADI-UHFFFAOYSA-N 5-[bis(2-chloroethyl)amino]uracil Chemical compound ClCCN(CCCl)C1=CNC(=O)NC1=O IDPUKCWIGUEADI-UHFFFAOYSA-N 0.000 claims 1
• NMUSYJAQQFHJEW-KVTDHHQDSA-N 5-azacytidine Chemical compound O=C1N=C(N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 NMUSYJAQQFHJEW-KVTDHHQDSA-N 0.000 claims 1
• BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 claims 1
• WYXSYVWAUAUWLD-SHUUEZRQSA-N 6-azauridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=N1 WYXSYVWAUAUWLD-SHUUEZRQSA-N 0.000 claims 1
• YCWQAMGASJSUIP-YFKPBYRVSA-N 6-diazo-5-oxo-L-norleucine Chemical compound OC(=O)[C@@H](N)CCC(=O)C=[N+]=[N-] YCWQAMGASJSUIP-YFKPBYRVSA-N 0.000 claims 1
• 229960005538 6-diazo-5-oxo-L-norleucine Drugs 0.000 claims 1
• ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 claims 1
• HDZZVAMISRMYHH-UHFFFAOYSA-N 9beta-Ribofuranosyl-7-deazaadenin Natural products C1=CC=2C(N)=NC=NC=2N1C1OC(CO)C(O)C1O HDZZVAMISRMYHH-UHFFFAOYSA-N 0.000 claims 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
• 208000002874 Acne Vulgaris Diseases 0.000 claims 1
• 208000003200 Adenoma Diseases 0.000 claims 1
• 206010001233 Adenoma benign Diseases 0.000 claims 1
• CEIZFXOZIQNICU-UHFFFAOYSA-N Alternaria alternata Crofton-weed toxin Natural products CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 claims 1
• 206010060937 Amniotic cavity infection Diseases 0.000 claims 1
• 206010002383 Angina Pectoris Diseases 0.000 claims 1
• 206010003011 Appendicitis Diseases 0.000 claims 1
• 206010003210 Arteriosclerosis Diseases 0.000 claims 1
• 208000005440 Basal Cell Neoplasms Diseases 0.000 claims 1
• VGGGPCQERPFHOB-MCIONIFRSA-N Bestatin Chemical compound CC(C)C[C@H](C(O)=O)NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1 VGGGPCQERPFHOB-MCIONIFRSA-N 0.000 claims 1
• 108010006654 Bleomycin Proteins 0.000 claims 1
• 208000006386 Bone Resorption Diseases 0.000 claims 1
• 208000020084 Bone disease Diseases 0.000 claims 1
• 206010006448 Bronchiolitis Diseases 0.000 claims 1
• 206010006458 Bronchitis chronic Diseases 0.000 claims 1
• COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 claims 1
• 229940127291 Calcium channel antagonist Drugs 0.000 claims 1
• GAGWJHPBXLXJQN-UHFFFAOYSA-N Capecitabine Natural products C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1C1C(O)C(O)C(C)O1 GAGWJHPBXLXJQN-UHFFFAOYSA-N 0.000 claims 1
• AOCCBINRVIKJHY-UHFFFAOYSA-N Carmofur Chemical compound CCCCCCNC(=O)N1C=C(F)C(=O)NC1=O AOCCBINRVIKJHY-UHFFFAOYSA-N 0.000 claims 1
• DLGOEMSEDOSKAD-UHFFFAOYSA-N Carmustine Chemical compound ClCCNC(=O)N(N=O)CCCl DLGOEMSEDOSKAD-UHFFFAOYSA-N 0.000 claims 1
• 206010007710 Cartilage injury Diseases 0.000 claims 1
• 239000005973 Carvone Substances 0.000 claims 1
• JWBOIMRXGHLCPP-UHFFFAOYSA-N Chloditan Chemical compound C=1C=CC=C(Cl)C=1C(C(Cl)Cl)C1=CC=C(Cl)C=C1 JWBOIMRXGHLCPP-UHFFFAOYSA-N 0.000 claims 1
• MKQWTWSXVILIKJ-LXGUWJNJSA-N Chlorozotocin Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](C=O)NC(=O)N(N=O)CCCl MKQWTWSXVILIKJ-LXGUWJNJSA-N 0.000 claims 1
• 208000008158 Chorioamnionitis Diseases 0.000 claims 1
• 208000001333 Colorectal Neoplasms Diseases 0.000 claims 1
• CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 claims 1
• PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 claims 1
• 108010036949 Cyclosporine Proteins 0.000 claims 1
• UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 claims 1
• WEAHRLBPCANXCN-UHFFFAOYSA-N Daunomycin Natural products CCC1(O)CC(OC2CC(N)C(O)C(C)O2)c3cc4C(=O)c5c(OC)cccc5C(=O)c4c(O)c3C1 WEAHRLBPCANXCN-UHFFFAOYSA-N 0.000 claims 1
• 206010012434 Dermatitis allergic Diseases 0.000 claims 1
• 206010012689 Diabetic retinopathy Diseases 0.000 claims 1
• 208000004145 Endometritis Diseases 0.000 claims 1
• SAMRUMKYXPVKPA-VFKOLLTISA-N Enocitabine Chemical compound O=C1N=C(NC(=O)CCCCCCCCCCCCCCCCCCCCC)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 SAMRUMKYXPVKPA-VFKOLLTISA-N 0.000 claims 1
• 201000011275 Epicondylitis Diseases 0.000 claims 1
• HTIJFSOGRVMCQR-UHFFFAOYSA-N Epirubicin Natural products COc1cccc2C(=O)c3c(O)c4CC(O)(CC(OC5CC(N)C(=O)C(C)O5)c4c(O)c3C(=O)c12)C(=O)CO HTIJFSOGRVMCQR-UHFFFAOYSA-N 0.000 claims 1
• OBMLHUPNRURLOK-XGRAFVIBSA-N Epitiostanol Chemical compound C1[C@@H]2S[C@@H]2C[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 OBMLHUPNRURLOK-XGRAFVIBSA-N 0.000 claims 1
• 208000000461 Esophageal Neoplasms Diseases 0.000 claims 1
• 108010008165 Etanercept Proteins 0.000 claims 1
• JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims 1
• 206010016228 Fasciitis Diseases 0.000 claims 1
• KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 claims 1
• 206010016935 Follicular thyroid cancer Diseases 0.000 claims 1
• BLCLNMBMMGCOAS-URPVMXJPSA-N Goserelin Chemical compound C([C@@H](C(=O)N[C@H](COC(C)(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(=O)NNC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 BLCLNMBMMGCOAS-URPVMXJPSA-N 0.000 claims 1
• 108010069236 Goserelin Proteins 0.000 claims 1
• 208000009329 Graft vs Host Disease Diseases 0.000 claims 1
• ZIXGXMMUKPLXBB-UHFFFAOYSA-N Guatambuinine Natural products N1C2=CC=CC=C2C2=C1C(C)=C1C=CN=C(C)C1=C2 ZIXGXMMUKPLXBB-UHFFFAOYSA-N 0.000 claims 1
• MPBVHIBUJCELCL-UHFFFAOYSA-N Ibandronate Chemical compound CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O MPBVHIBUJCELCL-UHFFFAOYSA-N 0.000 claims 1
• HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims 1
• XDXDZDZNSLXDNA-TZNDIEGXSA-N Idarubicin Chemical compound C1[C@H](N)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2C[C@@](O)(C(C)=O)C1 XDXDZDZNSLXDNA-TZNDIEGXSA-N 0.000 claims 1
• XDXDZDZNSLXDNA-UHFFFAOYSA-N Idarubicin Natural products C1C(N)C(O)C(C)OC1OC1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2CC(O)(C(C)=O)C1 XDXDZDZNSLXDNA-UHFFFAOYSA-N 0.000 claims 1
• 206010021980 Inflammatory carcinoma of the breast Diseases 0.000 claims 1
• 102000015696 Interleukins Human genes 0.000 claims 1
• 108010063738 Interleukins Proteins 0.000 claims 1
• 208000029523 Interstitial Lung disease Diseases 0.000 claims 1
• 206010023232 Joint swelling Diseases 0.000 claims 1
• 239000005411 L01XE02 - Gefitinib Substances 0.000 claims 1
• 201000008197 Laryngitis Diseases 0.000 claims 1
• 229920001491 Lentinan Polymers 0.000 claims 1
• 108010000817 Leuprolide Proteins 0.000 claims 1
• 208000019693 Lung disease Diseases 0.000 claims 1
• 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
• 102000008135 Mechanistic Target of Rapamycin Complex 1 Human genes 0.000 claims 1
• 108010035196 Mechanistic Target of Rapamycin Complex 1 Proteins 0.000 claims 1
• 102000009308 Mechanistic Target of Rapamycin Complex 2 Human genes 0.000 claims 1
• 108010034057 Mechanistic Target of Rapamycin Complex 2 Proteins 0.000 claims 1
• 208000009018 Medullary thyroid cancer Diseases 0.000 claims 1
• 229920000877 Melamine resin Polymers 0.000 claims 1
• 201000009906 Meningitis Diseases 0.000 claims 1
• 229930192392 Mitomycin Natural products 0.000 claims 1
• UCHDWCPVSPXUMX-TZIWLTJVSA-N Montelukast Chemical compound CC(C)(O)C1=CC=CC=C1CC[C@H](C=1C=C(\C=C\C=2N=C3C=C(Cl)C=CC3=CC=2)C=CC=1)SCC1(CC(O)=O)CC1 UCHDWCPVSPXUMX-TZIWLTJVSA-N 0.000 claims 1
• 208000003926 Myelitis Diseases 0.000 claims 1
• 208000009525 Myocarditis Diseases 0.000 claims 1
• 201000002481 Myositis Diseases 0.000 claims 1
• LKJPYSCBVHEWIU-UHFFFAOYSA-N N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide Chemical compound C=1C=C(C#N)C(C(F)(F)F)=CC=1NC(=O)C(O)(C)CS(=O)(=O)C1=CC=C(F)C=C1 LKJPYSCBVHEWIU-UHFFFAOYSA-N 0.000 claims 1
• BLXXJMDCKKHMKV-UHFFFAOYSA-N Nabumetone Chemical compound C1=C(CCC(C)=O)C=CC2=CC(OC)=CC=C21 BLXXJMDCKKHMKV-UHFFFAOYSA-N 0.000 claims 1
• CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 claims 1
• SYNHCENRCUAUNM-UHFFFAOYSA-N Nitrogen mustard N-oxide hydrochloride Chemical compound Cl.ClCC[N+]([O-])(C)CCCl SYNHCENRCUAUNM-UHFFFAOYSA-N 0.000 claims 1
• 206010030155 Oesophageal carcinoma Diseases 0.000 claims 1
• 229930187135 Olivomycin Natural products 0.000 claims 1
• 206010031252 Osteomyelitis Diseases 0.000 claims 1
• 208000005141 Otitis Diseases 0.000 claims 1
• 229930012538 Paclitaxel Natural products 0.000 claims 1
• 208000002193 Pain Diseases 0.000 claims 1
• 206010033645 Pancreatitis Diseases 0.000 claims 1
• 241001111421 Pannus Species 0.000 claims 1
• 206010033701 Papillary thyroid cancer Diseases 0.000 claims 1
• 206010034038 Parotitis Diseases 0.000 claims 1
• KMSKQZKKOZQFFG-HSUXVGOQSA-N Pirarubicin Chemical compound O([C@H]1[C@@H](N)C[C@@H](O[C@H]1C)O[C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1CCCCO1 KMSKQZKKOZQFFG-HSUXVGOQSA-N 0.000 claims 1
• 208000033759 Prolymphocytic T-Cell Leukemia Diseases 0.000 claims 1
• SUYXJDLXGFPMCQ-INIZCTEOSA-N SJ000287331 Natural products CC1=c2cnccc2=C(C)C2=Nc3ccccc3[C@H]12 SUYXJDLXGFPMCQ-INIZCTEOSA-N 0.000 claims 1
• 229920002305 Schizophyllan Polymers 0.000 claims 1
• 108010023197 Streptokinase Proteins 0.000 claims 1
• 208000029052 T-cell acute lymphoblastic leukemia Diseases 0.000 claims 1
• 206010042970 T-cell chronic lymphocytic leukaemia Diseases 0.000 claims 1
• 208000026651 T-cell prolymphocytic leukemia Diseases 0.000 claims 1
• 210000001744 T-lymphocyte Anatomy 0.000 claims 1
• 208000000491 Tendinopathy Diseases 0.000 claims 1
• 206010043255 Tendonitis Diseases 0.000 claims 1
• CGMTUJFWROPELF-UHFFFAOYSA-N Tenuazonic acid Natural products CCC(C)C1NC(=O)C(=C(C)/O)C1=O CGMTUJFWROPELF-UHFFFAOYSA-N 0.000 claims 1
• 201000009365 Thymic carcinoma Diseases 0.000 claims 1
• DQHNAVOVODVIMG-UHFFFAOYSA-M Tiotropium bromide Chemical compound [Br-].C1C(C2C3O2)[N+](C)(C)C3CC1OC(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 DQHNAVOVODVIMG-UHFFFAOYSA-M 0.000 claims 1
• 102000004887 Transforming Growth Factor beta Human genes 0.000 claims 1
• 108090001012 Transforming Growth Factor beta Proteins 0.000 claims 1
• UMILHIMHKXVDGH-UHFFFAOYSA-N Triethylene glycol diglycidyl ether Chemical compound C1OC1COCCOCCOCCOCC1CO1 UMILHIMHKXVDGH-UHFFFAOYSA-N 0.000 claims 1
• FYAMXEPQQLNQDM-UHFFFAOYSA-N Tris(1-aziridinyl)phosphine oxide Chemical compound C1CN1P(N1CC1)(=O)N1CC1 FYAMXEPQQLNQDM-UHFFFAOYSA-N 0.000 claims 1
• 108090000435 Urokinase-type plasminogen activator Proteins 0.000 claims 1
• 102000003990 Urokinase-type plasminogen activator Human genes 0.000 claims 1
• 206010046742 Urticaria contact Diseases 0.000 claims 1
• 208000006374 Uterine Cervicitis Diseases 0.000 claims 1
• 206010046914 Vaginal infection Diseases 0.000 claims 1
• 201000008100 Vaginitis Diseases 0.000 claims 1
• 206010053648 Vascular occlusion Diseases 0.000 claims 1
• 208000014070 Vestibular schwannoma Diseases 0.000 claims 1
• JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 claims 1
• 208000003728 Vulvodynia Diseases 0.000 claims 1
• 206010069055 Vulvovaginal pain Diseases 0.000 claims 1
• SPJCRMJCFSJKDE-ZWBUGVOYSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 2-[4-[bis(2-chloroethyl)amino]phenyl]acetate Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)C(=O)CC1=CC=C(N(CCCl)CCCl)C=C1 SPJCRMJCFSJKDE-ZWBUGVOYSA-N 0.000 claims 1
• YYAZJTUGSQOFHG-IAVNQIGZSA-N [(6s,8s,10s,11s,13s,14s,16r,17r)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate;2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]eth Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)C1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O YYAZJTUGSQOFHG-IAVNQIGZSA-N 0.000 claims 1
• XZSRRNFBEIOBDA-CFNBKWCHSA-N [2-[(2s,4s)-4-[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1h-tetracen-2-yl]-2-oxoethyl] 2,2-diethoxyacetate Chemical compound O([C@H]1C[C@](CC2=C(O)C=3C(=O)C4=CC=CC(OC)=C4C(=O)C=3C(O)=C21)(O)C(=O)COC(=O)C(OCC)OCC)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 XZSRRNFBEIOBDA-CFNBKWCHSA-N 0.000 claims 1
• 206010000269 abscess Diseases 0.000 claims 1
• 229940022663 acetate Drugs 0.000 claims 1
• 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims 1
• 239000002253 acid Substances 0.000 claims 1
• 229930188522 aclacinomycin Natural products 0.000 claims 1
• USZYSDMBJDPRIF-SVEJIMAYSA-N aclacinomycin A Chemical compound O([C@H]1[C@@H](O)C[C@@H](O[C@H]1C)O[C@H]1[C@H](C[C@@H](O[C@H]1C)O[C@H]1C[C@]([C@@H](C2=CC=3C(=O)C4=CC=CC(O)=C4C(=O)C=3C(O)=C21)C(=O)OC)(O)CC)N(C)C)[C@H]1CCC(=O)[C@H](C)O1 USZYSDMBJDPRIF-SVEJIMAYSA-N 0.000 claims 1
• 229960004176 aclarubicin Drugs 0.000 claims 1
• 206010000496 acne Diseases 0.000 claims 1
• 208000009621 actinic keratosis Diseases 0.000 claims 1
• 229930183665 actinomycin Natural products 0.000 claims 1
• RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 claims 1
• 229940009456 adriamycin Drugs 0.000 claims 1
• 229940090167 advair Drugs 0.000 claims 1
• 206010064930 age-related macular degeneration Diseases 0.000 claims 1
• SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims 1
• 208000026935 allergic disease Diseases 0.000 claims 1
• 230000007815 allergy Effects 0.000 claims 1
• 229960000473 altretamine Drugs 0.000 claims 1
• ROBVIMPUHSLWNV-UHFFFAOYSA-N aminoglutethimide Chemical compound C=1C=C(N)C=CC=1C1(CC)CCC(=O)NC1=O ROBVIMPUHSLWNV-UHFFFAOYSA-N 0.000 claims 1
• 229960003437 aminoglutethimide Drugs 0.000 claims 1
• 229960002749 aminolevulinic acid Drugs 0.000 claims 1
• 229960003896 aminopterin Drugs 0.000 claims 1
• XCPGHVQEEXUHNC-UHFFFAOYSA-N amsacrine Chemical compound COC1=CC(NS(C)(=O)=O)=CC=C1NC1=C(C=CC=C2)C2=NC2=CC=CC=C12 XCPGHVQEEXUHNC-UHFFFAOYSA-N 0.000 claims 1
• 229960001220 amsacrine Drugs 0.000 claims 1
• YBBLVLTVTVSKRW-UHFFFAOYSA-N anastrozole Chemical compound N#CC(C)(C)C1=CC(C(C)(C#N)C)=CC(CN2N=CN=C2)=C1 YBBLVLTVTVSKRW-UHFFFAOYSA-N 0.000 claims 1
• BBDAGFIXKZCXAH-CCXZUQQUSA-N ancitabine Chemical compound N=C1C=CN2[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3OC2=N1 BBDAGFIXKZCXAH-CCXZUQQUSA-N 0.000 claims 1
• 229950000242 ancitabine Drugs 0.000 claims 1
• 230000003367 anti-collagen effect Effects 0.000 claims 1
• 150000008209 arabinosides Chemical class 0.000 claims 1
• 229940078010 arimidex Drugs 0.000 claims 1
• 208000011775 arteriosclerosis disease Diseases 0.000 claims 1
• 206010003549 asthenia Diseases 0.000 claims 1
• 229940120638 avastin Drugs 0.000 claims 1
• 229940003504 avonex Drugs 0.000 claims 1
• 229960002756 azacitidine Drugs 0.000 claims 1
• VSRXQHXAPYXROS-UHFFFAOYSA-N azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) Chemical compound [NH2-].[NH2-].[Pt+2].OC(=O)C1(C(O)=O)CCC1 VSRXQHXAPYXROS-UHFFFAOYSA-N 0.000 claims 1
• 229950011321 azaserine Drugs 0.000 claims 1
• 229960002170 azathioprine Drugs 0.000 claims 1
• LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 claims 1
• 229950008548 bisantrene Drugs 0.000 claims 1
• 229960001561 bleomycin Drugs 0.000 claims 1
• OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 claims 1
• 208000010217 blepharitis Diseases 0.000 claims 1
• 230000024279 bone resorption Effects 0.000 claims 1
• 229960001467 bortezomib Drugs 0.000 claims 1
• 210000000481 breast Anatomy 0.000 claims 1
• 210000000621 bronchi Anatomy 0.000 claims 1
• 201000009267 bronchiectasis Diseases 0.000 claims 1
• 229960002092 busulfan Drugs 0.000 claims 1
• 108700002839 cactinomycin Proteins 0.000 claims 1
• 229950009908 cactinomycin Drugs 0.000 claims 1
• 239000000480 calcium channel blocker Substances 0.000 claims 1
• 229930195731 calicheamicin Natural products 0.000 claims 1
• HXCHCVDVKSCDHU-LULTVBGHSA-N calicheamicin Chemical compound C1[C@H](OC)[C@@H](NCC)CO[C@H]1O[C@H]1[C@H](O[C@@H]2C\3=C(NC(=O)OC)C(=O)C[C@](C/3=C/CSSSC)(O)C#C\C=C/C#C2)O[C@H](C)[C@@H](NO[C@@H]2O[C@H](C)[C@@H](SC(=O)C=3C(=C(OC)C(O[C@H]4[C@@H]([C@H](OC)[C@@H](O)[C@H](C)O4)O)=C(I)C=3C)OC)[C@@H](O)C2)[C@@H]1O HXCHCVDVKSCDHU-LULTVBGHSA-N 0.000 claims 1
• 229960004117 capecitabine Drugs 0.000 claims 1
• 229960004562 carboplatin Drugs 0.000 claims 1
• 150000001735 carboxylic acids Chemical class 0.000 claims 1
• 229930188550 carminomycin Natural products 0.000 claims 1
• XREUEWVEMYWFFA-CSKJXFQVSA-N carminomycin Chemical compound C1[C@H](N)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1C2=C(O)C(C(=O)C3=C(O)C=CC=C3C3=O)=C3C(O)=C2C[C@@](O)(C(C)=O)C1 XREUEWVEMYWFFA-CSKJXFQVSA-N 0.000 claims 1
• XREUEWVEMYWFFA-UHFFFAOYSA-N carminomycin I Natural products C1C(N)C(O)C(C)OC1OC1C2=C(O)C(C(=O)C3=C(O)C=CC=C3C3=O)=C3C(O)=C2CC(O)(C(C)=O)C1 XREUEWVEMYWFFA-UHFFFAOYSA-N 0.000 claims 1
• 229960003261 carmofur Drugs 0.000 claims 1
• 229960005243 carmustine Drugs 0.000 claims 1
• 229950001725 carubicin Drugs 0.000 claims 1
• 229940097647 casodex Drugs 0.000 claims 1
• 210000003169 central nervous system Anatomy 0.000 claims 1
• 206010008323 cervicitis Diseases 0.000 claims 1
• 125000001309 chloro group Chemical group Cl* 0.000 claims 1
• 229960003677 chloroquine Drugs 0.000 claims 1
• WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 claims 1
• 229960001480 chlorozotocin Drugs 0.000 claims 1
• 208000003167 cholangitis Diseases 0.000 claims 1
• ZYVSOIYQKUDENJ-WKSBCEQHSA-N chromomycin A3 Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@@H]1OC(C)=O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](O[C@@H]3O[C@@H](C)[C@H](OC(C)=O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@@H]1C[C@@H](O)[C@@H](OC)[C@@H](C)O1 ZYVSOIYQKUDENJ-WKSBCEQHSA-N 0.000 claims 1
• 208000007451 chronic bronchitis Diseases 0.000 claims 1
• 230000001684 chronic effect Effects 0.000 claims 1
• 229960001265 ciclosporin Drugs 0.000 claims 1
• DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 claims 1
• 229960004316 cisplatin Drugs 0.000 claims 1
• 229960001338 colchicine Drugs 0.000 claims 1
• 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
• 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
• 229960004397 cyclophosphamide Drugs 0.000 claims 1
• 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
• 229930182912 cyclosporin Natural products 0.000 claims 1
• 229960000684 cytarabine Drugs 0.000 claims 1
• 231100000433 cytotoxic Toxicity 0.000 claims 1
• 230000001472 cytotoxic effect Effects 0.000 claims 1
• 229960003901 dacarbazine Drugs 0.000 claims 1
• 229960000640 dactinomycin Drugs 0.000 claims 1
• 229960000975 daunorubicin Drugs 0.000 claims 1
• 210000004443 dendritic cell Anatomy 0.000 claims 1
• 201000001981 dermatomyositis Diseases 0.000 claims 1
• 229950003913 detorubicin Drugs 0.000 claims 1
• WVYXNIXAMZOZFK-UHFFFAOYSA-N diaziquone Chemical compound O=C1C(NC(=O)OCC)=C(N2CC2)C(=O)C(NC(=O)OCC)=C1N1CC1 WVYXNIXAMZOZFK-UHFFFAOYSA-N 0.000 claims 1
• 229950002389 diaziquone Drugs 0.000 claims 1
• 208000016097 disease of metabolism Diseases 0.000 claims 1
• 239000003534 dna topoisomerase inhibitor Substances 0.000 claims 1
• 229960003668 docetaxel Drugs 0.000 claims 1
• 229960004679 doxorubicin Drugs 0.000 claims 1
• NOTIQUSPUUHHEH-UXOVVSIBSA-N dromostanolone propionate Chemical compound C([C@@H]1CC2)C(=O)[C@H](C)C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](OC(=O)CC)[C@@]2(C)CC1 NOTIQUSPUUHHEH-UXOVVSIBSA-N 0.000 claims 1
• 229950004683 drostanolone propionate Drugs 0.000 claims 1
• 229940079593 drug Drugs 0.000 claims 1
• 208000001848 dysentery Diseases 0.000 claims 1
• 208000019258 ear infection Diseases 0.000 claims 1
• 230000000694 effects Effects 0.000 claims 1
• VLCYCQAOQCDTCN-UHFFFAOYSA-N eflornithine Chemical compound NCCCC(N)(C(F)F)C(O)=O VLCYCQAOQCDTCN-UHFFFAOYSA-N 0.000 claims 1
• 229940073621 enbrel Drugs 0.000 claims 1
• 229950011487 enocitabine Drugs 0.000 claims 1
• 210000000918 epididymis Anatomy 0.000 claims 1
• 201000010063 epididymitis Diseases 0.000 claims 1
• 229960001904 epirubicin Drugs 0.000 claims 1
• 229950002973 epitiostanol Drugs 0.000 claims 1
• KAQKFAOMNZTLHT-VVUHWYTRSA-N epoprostenol Chemical compound O1C(=CCCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-VVUHWYTRSA-N 0.000 claims 1
• 229960001123 epoprostenol Drugs 0.000 claims 1
• 229940082789 erbitux Drugs 0.000 claims 1
• 201000004101 esophageal cancer Diseases 0.000 claims 1
• 229950002017 esorubicin Drugs 0.000 claims 1
• ITSGNOIFAJAQHJ-BMFNZSJVSA-N esorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)C[C@H](C)O1 ITSGNOIFAJAQHJ-BMFNZSJVSA-N 0.000 claims 1
• 229960001842 estramustine Drugs 0.000 claims 1
• FRPJXPJMRWBBIH-RBRWEJTLSA-N estramustine Chemical compound ClCCN(CCCl)C(=O)OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 FRPJXPJMRWBBIH-RBRWEJTLSA-N 0.000 claims 1
• 229960005237 etoglucid Drugs 0.000 claims 1
• VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 claims 1
• 208000024519 eye neoplasm Diseases 0.000 claims 1
• 229960000961 floxuridine Drugs 0.000 claims 1
• ODKNJVUHOIMIIZ-RRKCRQDMSA-N floxuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(F)=C1 ODKNJVUHOIMIIZ-RRKCRQDMSA-N 0.000 claims 1
• MKXKFYHWDHIYRV-UHFFFAOYSA-N flutamide Chemical compound CC(C)C(=O)NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 MKXKFYHWDHIYRV-UHFFFAOYSA-N 0.000 claims 1
• 229960002074 flutamide Drugs 0.000 claims 1
• 229940044658 gallium nitrate Drugs 0.000 claims 1
• 230000002496 gastric effect Effects 0.000 claims 1
• 201000011587 gastric lymphoma Diseases 0.000 claims 1
• 208000017211 gastric neuroendocrine tumor G1 Diseases 0.000 claims 1
• XGALLCVXEZPNRQ-UHFFFAOYSA-N gefitinib Chemical compound C=12C=C(OCCCN3CCOCC3)C(OC)=CC2=NC=NC=1NC1=CC=C(F)C(Cl)=C1 XGALLCVXEZPNRQ-UHFFFAOYSA-N 0.000 claims 1
• 229960002584 gefitinib Drugs 0.000 claims 1
• 229960005277 gemcitabine Drugs 0.000 claims 1
• SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 claims 1
• 229930182470 glycoside Natural products 0.000 claims 1
• 229960002913 goserelin Drugs 0.000 claims 1
• 208000024908 graft versus host disease Diseases 0.000 claims 1
• 201000011066 hemangioma Diseases 0.000 claims 1
• 206010073071 hepatocellular carcinoma Diseases 0.000 claims 1
• 231100000844 hepatocellular carcinoma Toxicity 0.000 claims 1
• 229940022353 herceptin Drugs 0.000 claims 1
• UUVWYPNAQBNQJQ-UHFFFAOYSA-N hexamethylmelamine Chemical compound CN(C)C1=NC(N(C)C)=NC(N(C)C)=N1 UUVWYPNAQBNQJQ-UHFFFAOYSA-N 0.000 claims 1
• 229940048921 humira Drugs 0.000 claims 1
• 229960002050 hydrofluoric acid Drugs 0.000 claims 1
• 125000004356 hydroxy functional group Chemical group O* 0.000 claims 1
• XXSMGPRMXLTPCZ-UHFFFAOYSA-N hydroxychloroquine Chemical compound ClC1=CC=C2C(NC(C)CCCN(CCO)CC)=CC=NC2=C1 XXSMGPRMXLTPCZ-UHFFFAOYSA-N 0.000 claims 1
• 229960004171 hydroxychloroquine Drugs 0.000 claims 1
• 229940015872 ibandronate Drugs 0.000 claims 1
• 229960001680 ibuprofen Drugs 0.000 claims 1
• 229960000908 idarubicin Drugs 0.000 claims 1
• 229960003685 imatinib mesylate Drugs 0.000 claims 1
• YLMAHDNUQAMNNX-UHFFFAOYSA-N imatinib methanesulfonate Chemical group CS(O)(=O)=O.C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 YLMAHDNUQAMNNX-UHFFFAOYSA-N 0.000 claims 1
• 229950008097 improsulfan Drugs 0.000 claims 1
• DBIGHPPNXATHOF-UHFFFAOYSA-N improsulfan Chemical compound CS(=O)(=O)OCCCNCCCOS(C)(=O)=O DBIGHPPNXATHOF-UHFFFAOYSA-N 0.000 claims 1
• 229960000905 indomethacin Drugs 0.000 claims 1
• 201000004653 inflammatory breast carcinoma Diseases 0.000 claims 1
• 230000002401 inhibitory effect Effects 0.000 claims 1
• 229940047122 interleukins Drugs 0.000 claims 1
• 201000004614 iritis Diseases 0.000 claims 1
• 208000001875 irritant dermatitis Diseases 0.000 claims 1
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
• 150000002596 lactones Chemical class 0.000 claims 1
• 229940115286 lentinan Drugs 0.000 claims 1
• GFIJNRVAKGFPGQ-LIJARHBVSA-N leuprolide Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 GFIJNRVAKGFPGQ-LIJARHBVSA-N 0.000 claims 1
• 229960004338 leuprorelin Drugs 0.000 claims 1
• 208000014018 liver neoplasm Diseases 0.000 claims 1
• 229960003538 lonidamine Drugs 0.000 claims 1
• WDRYRZXSPDWGEB-UHFFFAOYSA-N lonidamine Chemical compound C12=CC=CC=C2C(C(=O)O)=NN1CC1=CC=C(Cl)C=C1Cl WDRYRZXSPDWGEB-UHFFFAOYSA-N 0.000 claims 1
• 210000004072 lung Anatomy 0.000 claims 1
• 201000005202 lung cancer Diseases 0.000 claims 1
• 208000020816 lung neoplasm Diseases 0.000 claims 1
• 210000004698 lymphocyte Anatomy 0.000 claims 1
• 230000000527 lymphocytic effect Effects 0.000 claims 1
• 208000002780 macular degeneration Diseases 0.000 claims 1
• 208000026037 malignant tumor of neck Diseases 0.000 claims 1
• MQXVYODZCMMZEM-ZYUZMQFOSA-N mannomustine Chemical compound ClCCNC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CNCCCl MQXVYODZCMMZEM-ZYUZMQFOSA-N 0.000 claims 1
• 229950008612 mannomustine Drugs 0.000 claims 1
• 238000004519 manufacturing process Methods 0.000 claims 1
• 208000023356 medullary thyroid gland carcinoma Diseases 0.000 claims 1
• JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 claims 1
• 229960001924 melphalan Drugs 0.000 claims 1
• SGDBTWWWUNNDEQ-LBPRGKRZSA-N melphalan Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N(CCCl)CCCl)C=C1 SGDBTWWWUNNDEQ-LBPRGKRZSA-N 0.000 claims 1
• 208000030159 metabolic disease Diseases 0.000 claims 1
• HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 claims 1
• 229960003539 mitoguazone Drugs 0.000 claims 1
• MXWHMTNPTTVWDM-NXOFHUPFSA-N mitoguazone Chemical compound NC(N)=N\N=C(/C)\C=N\N=C(N)N MXWHMTNPTTVWDM-NXOFHUPFSA-N 0.000 claims 1
• CPTIBDHUFVHUJK-NZYDNVMFSA-N mitopodozide Chemical compound C1([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H](CO)[C@@H]2C(=O)NNCC)=CC(OC)=C(OC)C(OC)=C1 CPTIBDHUFVHUJK-NZYDNVMFSA-N 0.000 claims 1
• 229960000350 mitotane Drugs 0.000 claims 1
• ZAHQPTJLOCWVPG-UHFFFAOYSA-N mitoxantrone dihydrochloride Chemical compound Cl.Cl.O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO ZAHQPTJLOCWVPG-UHFFFAOYSA-N 0.000 claims 1
• 229960005127 montelukast Drugs 0.000 claims 1
• 229950010718 mopidamol Drugs 0.000 claims 1
• FOYWNSCCNCUEPU-UHFFFAOYSA-N mopidamol Chemical compound C12=NC(N(CCO)CCO)=NC=C2N=C(N(CCO)CCO)N=C1N1CCCCC1 FOYWNSCCNCUEPU-UHFFFAOYSA-N 0.000 claims 1
• 206010028417 myasthenia gravis Diseases 0.000 claims 1
• 229960000951 mycophenolic acid Drugs 0.000 claims 1
• HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 claims 1
• NJSMWLQOCQIOPE-OCHFTUDZSA-N n-[(e)-[10-[(e)-(4,5-dihydro-1h-imidazol-2-ylhydrazinylidene)methyl]anthracen-9-yl]methylideneamino]-4,5-dihydro-1h-imidazol-2-amine Chemical compound N1CCN=C1N\N=C\C(C1=CC=CC=C11)=C(C=CC=C2)C2=C1\C=N\NC1=NCCN1 NJSMWLQOCQIOPE-OCHFTUDZSA-N 0.000 claims 1
• 229960004270 nabumetone Drugs 0.000 claims 1
• 229960002009 naproxen Drugs 0.000 claims 1
• CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 claims 1
• 229940086322 navelbine Drugs 0.000 claims 1
• QZGIWPZCWHMVQL-UIYAJPBUSA-N neocarzinostatin chromophore Chemical compound O1[C@H](C)[C@H](O)[C@H](O)[C@@H](NC)[C@H]1O[C@@H]1C/2=C/C#C[C@H]3O[C@@]3([C@@H]3OC(=O)OC3)C#CC\2=C[C@H]1OC(=O)C1=C(O)C=CC2=C(C)C=C(OC)C=C12 QZGIWPZCWHMVQL-UIYAJPBUSA-N 0.000 claims 1
• 210000005036 nerve Anatomy 0.000 claims 1
• 210000000440 neutrophil Anatomy 0.000 claims 1
• XWXYUMMDTVBTOU-UHFFFAOYSA-N nilutamide Chemical compound O=C1C(C)(C)NC(=O)N1C1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 XWXYUMMDTVBTOU-UHFFFAOYSA-N 0.000 claims 1
• 229960002653 nilutamide Drugs 0.000 claims 1
• 150000002823 nitrates Chemical class 0.000 claims 1
• 201000008106 ocular cancer Diseases 0.000 claims 1
• CZDBNBLGZNWKMC-MWQNXGTOSA-N olivomycin Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@@H]1O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1)O[C@H]1O[C@@H](C)[C@H](O)[C@@H](OC2O[C@@H](C)[C@H](O)[C@@H](O)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@H]1C[C@H](O)[C@H](OC)[C@H](C)O1 CZDBNBLGZNWKMC-MWQNXGTOSA-N 0.000 claims 1
• 229950005848 olivomycin Drugs 0.000 claims 1
• 229950011093 onapristone Drugs 0.000 claims 1
• 201000005737 orchitis Diseases 0.000 claims 1
• 229960001592 paclitaxel Drugs 0.000 claims 1
• FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims 1
• 229960002340 pentostatin Drugs 0.000 claims 1
• FPVKHBSQESCIEP-JQCXWYLXSA-N pentostatin Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC[C@H]2O)=C2N=C1 FPVKHBSQESCIEP-JQCXWYLXSA-N 0.000 claims 1
• 208000029255 peripheral nervous system cancer Diseases 0.000 claims 1
• 208000002440 photoallergic dermatitis Diseases 0.000 claims 1
• 208000007578 phototoxic dermatitis Diseases 0.000 claims 1
• 229960001221 pirarubicin Drugs 0.000 claims 1
• 229910052697 platinum Inorganic materials 0.000 claims 1
• 210000003281 pleural cavity Anatomy 0.000 claims 1
• XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 claims 1
• 229960004618 prednisone Drugs 0.000 claims 1
• 208000030266 primary brain neoplasm Diseases 0.000 claims 1
• CPTBDICYNRMXFX-UHFFFAOYSA-N procarbazine Chemical compound CNNCC1=CC=C(C(=O)NC(C)C)C=C1 CPTBDICYNRMXFX-UHFFFAOYSA-N 0.000 claims 1
• 229960000624 procarbazine Drugs 0.000 claims 1
• WOLQREOUPKZMEX-UHFFFAOYSA-N pteroyltriglutamic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(=O)NC(CCC(=O)NC(CCC(O)=O)C(O)=O)C(O)=O)C(O)=O)C=C1 WOLQREOUPKZMEX-UHFFFAOYSA-N 0.000 claims 1
• 229950010131 puromycin Drugs 0.000 claims 1
• 230000005855 radiation Effects 0.000 claims 1
• 229960004622 raloxifene Drugs 0.000 claims 1
• GZUITABIAKMVPG-UHFFFAOYSA-N raloxifene Chemical compound C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 GZUITABIAKMVPG-UHFFFAOYSA-N 0.000 claims 1
• 229940038850 rebif Drugs 0.000 claims 1
• 229940116176 remicade Drugs 0.000 claims 1
• 230000029058 respiratory gaseous exchange Effects 0.000 claims 1
• 210000002345 respiratory system Anatomy 0.000 claims 1
• 230000002207 retinal effect Effects 0.000 claims 1
• 229930002330 retinoic acid Natural products 0.000 claims 1
• 229960004641 rituximab Drugs 0.000 claims 1
• VHXNKPBCCMUMSW-FQEVSTJZSA-N rubitecan Chemical compound C1=CC([N+]([O-])=O)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VHXNKPBCCMUMSW-FQEVSTJZSA-N 0.000 claims 1
• 229960001860 salicylate Drugs 0.000 claims 1
• YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 claims 1
• 229960004889 salicylic acid Drugs 0.000 claims 1
• 210000002966 serum Anatomy 0.000 claims 1
• QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical class C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 claims 1
• 229940046810 spiriva Drugs 0.000 claims 1
• 229950006315 spirogermanium Drugs 0.000 claims 1
• 208000017572 squamous cell neoplasm Diseases 0.000 claims 1
• 208000003265 stomatitis Diseases 0.000 claims 1
• 229960005202 streptokinase Drugs 0.000 claims 1
• 229960001052 streptozocin Drugs 0.000 claims 1
• ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 claims 1
• 210000000106 sweat gland Anatomy 0.000 claims 1
• 201000004595 synovitis Diseases 0.000 claims 1
• 229960001603 tamoxifen Drugs 0.000 claims 1
• RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 1
• RCINICONZNJXQF-XAZOAEDWSA-N taxol® Chemical compound O([C@@H]1[C@@]2(CC(C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3(C21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-XAZOAEDWSA-N 0.000 claims 1
• 229940063683 taxotere Drugs 0.000 claims 1
• 201000004415 tendinitis Diseases 0.000 claims 1
• NRUKOCRGYNPUPR-QBPJDGROSA-N teniposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@@H](OC[C@H]4O3)C=3SC=CC=3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 NRUKOCRGYNPUPR-QBPJDGROSA-N 0.000 claims 1
• 229960001278 teniposide Drugs 0.000 claims 1
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims 1
• 229960001196 thiotepa Drugs 0.000 claims 1
• 208000030901 thyroid gland follicular carcinoma Diseases 0.000 claims 1
• 208000030045 thyroid gland papillary carcinoma Diseases 0.000 claims 1
• 206010044008 tonsillitis Diseases 0.000 claims 1
• 229940044693 topoisomerase inhibitor Drugs 0.000 claims 1
• XFCLJVABOIYOMF-QPLCGJKRSA-N toremifene Chemical compound C1=CC(OCCN(C)C)=CC=C1C(\C=1C=CC=CC=1)=C(\CCCl)C1=CC=CC=C1 XFCLJVABOIYOMF-QPLCGJKRSA-N 0.000 claims 1
• 229960005026 toremifene Drugs 0.000 claims 1
• 210000003437 trachea Anatomy 0.000 claims 1
• 229950001353 tretamine Drugs 0.000 claims 1
• IUCJMVBFZDHPDX-UHFFFAOYSA-N tretamine Chemical compound C1CN1C1=NC(N2CC2)=NC(N2CC2)=N1 IUCJMVBFZDHPDX-UHFFFAOYSA-N 0.000 claims 1
• 229960001727 tretinoin Drugs 0.000 claims 1
• KVJXBPDAXMEYOA-CXANFOAXSA-N trilostane Chemical compound OC1=C(C#N)C[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@@]32O[C@@H]31 KVJXBPDAXMEYOA-CXANFOAXSA-N 0.000 claims 1
• 229960001670 trilostane Drugs 0.000 claims 1
• NOYPYLRCIDNJJB-UHFFFAOYSA-N trimetrexate Chemical compound COC1=C(OC)C(OC)=CC(NCC=2C(=C3C(N)=NC(N)=NC3=CC=2)C)=C1 NOYPYLRCIDNJJB-UHFFFAOYSA-N 0.000 claims 1
• 229960001099 trimetrexate Drugs 0.000 claims 1
• 229960000875 trofosfamide Drugs 0.000 claims 1
• UMKFEPPTGMDVMI-UHFFFAOYSA-N trofosfamide Chemical compound ClCCN(CCCl)P1(=O)OCCCN1CCCl UMKFEPPTGMDVMI-UHFFFAOYSA-N 0.000 claims 1
• HDZZVAMISRMYHH-LITAXDCLSA-N tubercidin Chemical compound C1=CC=2C(N)=NC=NC=2N1[C@@H]1O[C@@H](CO)[C@H](O)[C@H]1O HDZZVAMISRMYHH-LITAXDCLSA-N 0.000 claims 1
• 229950009811 ubenimex Drugs 0.000 claims 1
• 229960001055 uracil mustard Drugs 0.000 claims 1
• 229960005088 urethane Drugs 0.000 claims 1
• 229960005356 urokinase Drugs 0.000 claims 1
• 208000021331 vascular occlusion disease Diseases 0.000 claims 1
• 229940099039 velcade Drugs 0.000 claims 1
• 229960003048 vinblastine Drugs 0.000 claims 1
• JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 claims 1
• 229960004528 vincristine Drugs 0.000 claims 1
• OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 claims 1
• OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 claims 1
• 229960004355 vindesine Drugs 0.000 claims 1
• UGGWPQSBPIFKDZ-KOTLKJBCSA-N vindesine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(N)=O)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1N=C1[C]2C=CC=C1 UGGWPQSBPIFKDZ-KOTLKJBCSA-N 0.000 claims 1
• GBABOYUKABKIAF-IELIFDKJSA-N vinorelbine Chemical compound C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC([C@]23[C@H]([C@@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC GBABOYUKABKIAF-IELIFDKJSA-N 0.000 claims 1
• 229960002066 vinorelbine Drugs 0.000 claims 1
• CILBMBUYJCWATM-PYGJLNRPSA-N vinorelbine ditartrate Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.OC(=O)[C@H](O)[C@@H](O)C(O)=O.C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC([C@]23[C@H]([C@@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC CILBMBUYJCWATM-PYGJLNRPSA-N 0.000 claims 1
• 208000002003 vulvitis Diseases 0.000 claims 1
• 229940053867 xeloda Drugs 0.000 claims 1
• 229940099073 xolair Drugs 0.000 claims 1
• 229950009268 zinostatin Drugs 0.000 claims 1
• 229960000641 zorubicin Drugs 0.000 claims 1
• FBTUMDXHSRTGRV-ALTNURHMSA-N zorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(\C)=N\NC(=O)C=1C=CC=CC=1)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 FBTUMDXHSRTGRV-ALTNURHMSA-N 0.000 claims 1
• 239000000203 mixture Substances 0.000 description 7
• 208000011580 syndromic disease Diseases 0.000 description 6
• 0 C[C@@](C(N1c2c(*)c(*)c(*)c(*)c2*)=Cc2cccc(Cl)c2C1=O)Nc1c2nc[n]c2ncn1 Chemical compound C[C@@](C(N1c2c(*)c(*)c(*)c(*)c2*)=Cc2cccc(Cl)c2C1=O)Nc1c2nc[n]c2ncn1 0.000 description 4
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
• 229910052799 carbon Inorganic materials 0.000 description 4
• 210000003491 skin Anatomy 0.000 description 3
• 208000030507 AIDS Diseases 0.000 description 2
• 208000032671 Allergic granulomatous angiitis Diseases 0.000 description 2
• 206010007275 Carcinoid tumour Diseases 0.000 description 2
• 208000006344 Churg-Strauss Syndrome Diseases 0.000 description 2
• 208000018428 Eosinophilic granulomatosis with polyangiitis Diseases 0.000 description 2
• 208000010159 IgA glomerulonephritis Diseases 0.000 description 2
• 206010021263 IgA nephropathy Diseases 0.000 description 2
• 206010069665 Mesenteritis Diseases 0.000 description 2
• 201000010105 allergic rhinitis Diseases 0.000 description 2
• 201000009240 nasopharyngitis Diseases 0.000 description 2
• 210000000277 pancreatic duct Anatomy 0.000 description 2
• 210000001550 testis Anatomy 0.000 description 2
• 210000001519 tissue Anatomy 0.000 description 2
• 208000010543 22q11.2 deletion syndrome Diseases 0.000 description 1
• 208000009663 Acute Necrotizing Pancreatitis Diseases 0.000 description 1
• 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
• 206010001076 Acute sinusitis Diseases 0.000 description 1
• 208000026326 Adult-onset Still disease Diseases 0.000 description 1
• 208000008190 Agammaglobulinemia Diseases 0.000 description 1
• 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
• 208000007887 Alphavirus Infections Diseases 0.000 description 1
• 208000024985 Alport syndrome Diseases 0.000 description 1
• 206010002198 Anaphylactic reaction Diseases 0.000 description 1
• 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
• 206010002921 Aortitis Diseases 0.000 description 1
• 206010053622 Asplenia Diseases 0.000 description 1
• 206010069002 Autoimmune pancreatitis Diseases 0.000 description 1
• 208000033241 Autosomal dominant hyper-IgE syndrome Diseases 0.000 description 1
• 208000009137 Behcet syndrome Diseases 0.000 description 1
• UMBOVTDDENNROQ-UHFFFAOYSA-N CC(C(N1c2ccccc2)=Cc2cccc(C)c2C1=O)Nc1c2nc[nH]c2ncn1 Chemical compound CC(C(N1c2ccccc2)=Cc2cccc(C)c2C1=O)Nc1c2nc[nH]c2ncn1 UMBOVTDDENNROQ-UHFFFAOYSA-N 0.000 description 1
• UMBOVTDDENNROQ-HNNXBMFYSA-N C[C@@H](C(N1c2ccccc2)=Cc(cccc2C)c2C1=O)Nc1c2nc[nH]c2ncn1 Chemical compound C[C@@H](C(N1c2ccccc2)=Cc(cccc2C)c2C1=O)Nc1c2nc[nH]c2ncn1 UMBOVTDDENNROQ-HNNXBMFYSA-N 0.000 description 1
• UMBOVTDDENNROQ-OAHLLOKOSA-N C[C@H](C(N1c2ccccc2)=Cc2cccc(C)c2C1=O)Nc1c2nc[nH]c2ncn1 Chemical compound C[C@H](C(N1c2ccccc2)=Cc2cccc(C)c2C1=O)Nc1c2nc[nH]c2ncn1 UMBOVTDDENNROQ-OAHLLOKOSA-N 0.000 description 1
• 201000009030 Carcinoma Diseases 0.000 description 1
• 206010009657 Clostridium difficile colitis Diseases 0.000 description 1
• 206010010744 Conjunctivitis allergic Diseases 0.000 description 1
• 206010057254 Connective tissue inflammation Diseases 0.000 description 1
• 206010012438 Dermatitis atopic Diseases 0.000 description 1
• 208000000398 DiGeorge Syndrome Diseases 0.000 description 1
• 201000004315 EAST syndrome Diseases 0.000 description 1
• 206010064212 Eosinophilic oesophagitis Diseases 0.000 description 1
• 206010066919 Epidemic polyarthritis Diseases 0.000 description 1
• 206010059284 Epidermal necrosis Diseases 0.000 description 1
• 206010015218 Erythema multiforme Diseases 0.000 description 1
• 208000010201 Exanthema Diseases 0.000 description 1
• 206010015943 Eye inflammation Diseases 0.000 description 1
• 208000004930 Fatty Liver Diseases 0.000 description 1
• 206010017807 Gastric mucosal hypertrophy Diseases 0.000 description 1
• 201000005569 Gout Diseases 0.000 description 1
• 206010018691 Granuloma Diseases 0.000 description 1
• 206010057212 Hepatitis viral infections Diseases 0.000 description 1
• 241000714260 Human T-lymphotropic virus 1 Species 0.000 description 1
• 208000019758 Hypergammaglobulinemia Diseases 0.000 description 1
• 206010020649 Hyperkeratosis Diseases 0.000 description 1
• 208000000239 Hypertrophic Gastritis Diseases 0.000 description 1
• 201000001431 Hyperuricemia Diseases 0.000 description 1
• 206010020983 Hypogammaglobulinaemia Diseases 0.000 description 1
• 206010061598 Immunodeficiency Diseases 0.000 description 1
• 208000029462 Immunodeficiency disease Diseases 0.000 description 1
• 108060003951 Immunoglobulin Proteins 0.000 description 1
• 208000004575 Infectious Arthritis Diseases 0.000 description 1
• 208000036633 Jejunitis Diseases 0.000 description 1
• 208000009388 Job Syndrome Diseases 0.000 description 1
• 208000003456 Juvenile Arthritis Diseases 0.000 description 1
• 206010059176 Juvenile idiopathic arthritis Diseases 0.000 description 1
• 208000011200 Kawasaki disease Diseases 0.000 description 1
• 208000001126 Keratosis Diseases 0.000 description 1
• 241000406668 Loxodonta cyclotis Species 0.000 description 1
• 208000016604 Lyme disease Diseases 0.000 description 1
• 208000008771 Lymphadenopathy Diseases 0.000 description 1
• 206010025282 Lymphoedema Diseases 0.000 description 1
• 206010025312 Lymphoma AIDS related Diseases 0.000 description 1
• 206010028116 Mucosal inflammation Diseases 0.000 description 1
• 201000010927 Mucositis Diseases 0.000 description 1
• 206010030216 Oesophagitis Diseases 0.000 description 1
• 241001420836 Ophthalmitis Species 0.000 description 1
• 206010068319 Oropharyngeal pain Diseases 0.000 description 1
• 206010058096 Pancreatic necrosis Diseases 0.000 description 1
• 241000282376 Panthera tigris Species 0.000 description 1
• 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
• 206010034464 Periarthritis Diseases 0.000 description 1
• 208000009019 Pericoronitis Diseases 0.000 description 1
• 206010071301 Perihepatitis Diseases 0.000 description 1
• 208000009565 Pharyngeal Neoplasms Diseases 0.000 description 1
• 206010034811 Pharyngeal cancer Diseases 0.000 description 1
• 206010036783 Proctitis ulcerative Diseases 0.000 description 1
• 208000003100 Pseudomembranous Enterocolitis Diseases 0.000 description 1
• 206010037128 Pseudomembranous colitis Diseases 0.000 description 1
• 201000001263 Psoriatic Arthritis Diseases 0.000 description 1
• 208000036824 Psoriatic arthropathy Diseases 0.000 description 1
• 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
• 206010039085 Rhinitis allergic Diseases 0.000 description 1
• 206010039094 Rhinitis perennial Diseases 0.000 description 1
• 208000036284 Rhinitis seasonal Diseases 0.000 description 1
• 241000566137 Sagittarius Species 0.000 description 1
• 206010058556 Serositis Diseases 0.000 description 1
• 208000019229 Spleen disease Diseases 0.000 description 1
• 206010041660 Splenomegaly Diseases 0.000 description 1
• 206010042033 Stevens-Johnson syndrome Diseases 0.000 description 1
• 231100000168 Stevens-Johnson syndrome Toxicity 0.000 description 1
• 206010044314 Tracheobronchitis Diseases 0.000 description 1
• 206010073104 Tubular breast carcinoma Diseases 0.000 description 1
• 208000002495 Uterine Neoplasms Diseases 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 208000012876 acute enteritis Diseases 0.000 description 1
• 201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
• 208000002205 allergic conjunctivitis Diseases 0.000 description 1
• 208000030961 allergic reaction Diseases 0.000 description 1
• 230000036783 anaphylactic response Effects 0.000 description 1
• 208000003455 anaphylaxis Diseases 0.000 description 1
• 230000000844 anti-bacterial effect Effects 0.000 description 1
• 208000024998 atopic conjunctivitis Diseases 0.000 description 1
• 208000002479 balanitis Diseases 0.000 description 1
• 201000005668 blepharoconjunctivitis Diseases 0.000 description 1
• 210000000988 bone and bone Anatomy 0.000 description 1
• 230000002308 calcification Effects 0.000 description 1
• 210000000845 cartilage Anatomy 0.000 description 1
• 201000004709 chorioretinitis Diseases 0.000 description 1
• 208000019069 chronic childhood arthritis Diseases 0.000 description 1
• 210000001268 chyle Anatomy 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 208000007784 diverticulitis Diseases 0.000 description 1
• 230000004064 dysfunction Effects 0.000 description 1
• 206010014599 encephalitis Diseases 0.000 description 1
• 201000000708 eosinophilic esophagitis Diseases 0.000 description 1
• 210000000981 epithelium Anatomy 0.000 description 1
• 208000006881 esophagitis Diseases 0.000 description 1
• 150000002148 esters Chemical class 0.000 description 1
• 201000005884 exanthem Diseases 0.000 description 1
• 201000005206 focal segmental glomerulosclerosis Diseases 0.000 description 1
• 231100000854 focal segmental glomerulosclerosis Toxicity 0.000 description 1
• 201000009277 hairy cell leukemia Diseases 0.000 description 1
• 230000002008 hemorrhagic effect Effects 0.000 description 1
• 208000003215 hereditary nephritis Diseases 0.000 description 1
• 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
• 208000014796 hyper-IgE recurrent infection syndrome 1 Diseases 0.000 description 1
• 206010051040 hyper-IgE syndrome Diseases 0.000 description 1
• 201000004108 hypersplenism Diseases 0.000 description 1
• 230000007813 immunodeficiency Effects 0.000 description 1
• 102000018358 immunoglobulin Human genes 0.000 description 1
• 208000002864 infectious keratoconjunctivitis Diseases 0.000 description 1
• 201000002696 invasive tubular breast carcinoma Diseases 0.000 description 1
• 208000002551 irritable bowel syndrome Diseases 0.000 description 1
• 201000002215 juvenile rheumatoid arthritis Diseases 0.000 description 1
• 206010023332 keratitis Diseases 0.000 description 1
• 201000010666 keratoconjunctivitis Diseases 0.000 description 1
• 208000003849 large cell carcinoma Diseases 0.000 description 1
• 210000000265 leukocyte Anatomy 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 230000001926 lymphatic effect Effects 0.000 description 1
• 208000018555 lymphatic system disease Diseases 0.000 description 1
• 208000002502 lymphedema Diseases 0.000 description 1
• 210000005075 mammary gland Anatomy 0.000 description 1
• 238000000034 method Methods 0.000 description 1
• 208000001725 mucocutaneous lymph node syndrome Diseases 0.000 description 1
• 201000000050 myeloid neoplasm Diseases 0.000 description 1
• 210000002445 nipple Anatomy 0.000 description 1
• 208000008338 non-alcoholic fatty liver disease Diseases 0.000 description 1
• 206010053219 non-alcoholic steatohepatitis Diseases 0.000 description 1
• 210000001328 optic nerve Anatomy 0.000 description 1
• 230000000242 pagocytic effect Effects 0.000 description 1
• 208000010403 panophthalmitis Diseases 0.000 description 1
• 208000022719 perennial allergic rhinitis Diseases 0.000 description 1
• 208000025223 poliovirus infection Diseases 0.000 description 1
• 201000006292 polyarteritis nodosa Diseases 0.000 description 1
• 229940002612 prodrug Drugs 0.000 description 1
• 239000000651 prodrug Substances 0.000 description 1
• 206010037844 rash Diseases 0.000 description 1
• 208000017022 seasonal allergic rhinitis Diseases 0.000 description 1
• 201000001223 septic arthritis Diseases 0.000 description 1
• 201000009890 sinusitis Diseases 0.000 description 1
• 210000004927 skin cell Anatomy 0.000 description 1
• 208000017520 skin disease Diseases 0.000 description 1
• 201000010106 skin squamous cell carcinoma Diseases 0.000 description 1
• 239000012453 solvate Substances 0.000 description 1
• 210000000278 spinal cord Anatomy 0.000 description 1
• 208000027140 splenic disease Diseases 0.000 description 1
• 210000000130 stem cell Anatomy 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 230000002381 testicular Effects 0.000 description 1
• 201000005060 thrombophlebitis Diseases 0.000 description 1
• 230000001732 thrombotic effect Effects 0.000 description 1
• 230000002992 thymic effect Effects 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 230000002485 urinary effect Effects 0.000 description 1
• 208000023747 urothelial carcinoma Diseases 0.000 description 1
• 206010046766 uterine cancer Diseases 0.000 description 1
• 210000004291 uterus Anatomy 0.000 description 1
• 210000003462 vein Anatomy 0.000 description 1